BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15498832)

  • 1. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization.
    Teli T; Markovic D; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2005 Feb; 19(2):474-90. PubMed ID: 15498832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
    Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
    Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.
    Markovic D; Punn A; Lehnert H; Grammatopoulos DK
    Mol Endocrinol; 2008 Mar; 22(3):689-706. PubMed ID: 18048641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
    Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
    J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation.
    Teli T; Markovic D; Hewitt ME; Levine MA; Hillhouse EW; Grammatopoulos DK
    Cell Signal; 2008 Jan; 20(1):40-9. PubMed ID: 17913459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor.
    Kelley-Hickie LP; Kinsella BT
    Biochim Biophys Acta; 2006 Sep; 1761(9):1114-31. PubMed ID: 16956790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL; Koehler JA; Yusta B; Drucker DJ
    J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
    Markovic D; Lehnert H; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2008 Nov; 22(11):2505-19. PubMed ID: 18772229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
    Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
    Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.
    Punn A; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2006 Dec; 20(12):3179-95. PubMed ID: 16959871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration.
    Markovic D; Punn A; Lehnert H; Grammatopoulos DK
    Biochim Biophys Acta; 2011 May; 1813(5):896-907. PubMed ID: 21338628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytoplasmic tail of the type 1A angiotensin II receptor in agonist- and phorbol ester-induced desensitization.
    Tang H; Guo DF; Porter JP; Wanaka Y; Inagami T
    Circ Res; 1998 Mar; 82(5):523-31. PubMed ID: 9529156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
    Ouedraogo M; Lecat S; Rochdi MD; Hachet-Haas M; Matthes H; Gicquiaux H; Verrier S; Gaire M; Glasser N; Mély Y; Takeda K; Bouvier M; Galzi JL; Bucher B
    Traffic; 2008 Mar; 9(3):305-24. PubMed ID: 18088318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
    Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
    J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses.
    Oakley RH; Olivares-Reyes JA; Hudson CC; Flores-Vega F; Dautzenberg FM; Hauger RL
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R209-22. PubMed ID: 17363685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment.
    Rasmussen TN; Novak I; Nielsen SM
    Eur J Biochem; 2004 Nov; 271(22):4366-74. PubMed ID: 15560778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.